Stuka Paul 4
4 · InspireMD, Inc. · Filed May 15, 2026
Research Summary
AI-generated summary of this filing
InspireMD (NSPR) Director Paul Stuka Buys 15,000 Shares
What Happened
Paul Stuka, a director of InspireMD, acquired a total of 15,000 common shares in two open‑market purchases: 10,000 shares reported at $1.16 (total $11,575) on 2026-05-13 and 5,000 shares at $1.15 (total $5,750) on 2026-05-14, for combined consideration of $17,325. The transactions were disclosed on a Form 4 filed 2026-05-15.
Key Details
- Transaction dates and amounts: 2026-05-13 — 10,000 shares @ $1.16 (reported total $11,575); 2026-05-14 — 5,000 shares @ $1.15 (reported total $5,750).
- Footnote on price: filing notes a weighted‑average price and that purchases occurred at prices ranging $1.1550–$1.1599.
- Holdings after transaction: the filing does not state total shares beneficially owned after these purchases.
- Footnote on ownership: some securities in the filing are held by Osiris Investment Partners, L.P.; Stuka is the managing member of the general partner and may be deemed to beneficially own such securities but disclaims ownership except to his pecuniary interest. The filing also states no transaction was effected by Stuka with respect to those Osiris-held securities — they are included for informational purposes.
- Filing timeliness: Form 4 was filed 2026-05-15 covering 2026-05-13 and 2026-05-14 trades; the report appears to have been filed within the normal reporting window.
Context
These are outright purchases (insider buys), which many investors view as a stronger informational signal than routine sales. The filing includes clarifying footnotes about weighted prices and institutional holding via Osiris; no options, grants, gifts, or tax‑withholding events are involved in these reported transactions.
Insider Transaction Report
- Purchase
Common Stock
[F1]2026-05-13$1.16/sh+10,000$11,575→ 642,871 total - Purchase
Common Stock
2026-05-14$1.15/sh+5,000$5,750→ 647,871 total
- 423,704(indirect: See Footnote)
Common Stock
[F2]
Footnotes (2)
- [F1]The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.1550 to $1.1599. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F2]These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.